(Q40153561)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26031574%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

title

Phase I trial of thymidylate synthase poly-epitope peptide (TSPP) vaccine in advanced cancer patients (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26031574%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

main subject

phase I clinical trial

0 references

author

Maria Grazia Cusi

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26031574%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

Cirino Botta

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26031574%20AND%20SRC:MED&resulttype=core&format=json

Salvatore Francesco Carbone

16 February 2020

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26031574%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

Pierpaolo Correale

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26031574%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

5

Elena Dreassi

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26031574%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

Pierfrancesco Tassone

15

object named as

Pierfrancesco Tassone

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26031574%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

Pierosandro Tagliaferri

16

object named as

Pierosandro Tagliaferri

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26031574%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

author name string

Pierpaolo Pastina

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26031574%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

Maria Grazia Rossetti

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26031574%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

Giacomo Maria Guidelli

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26031574%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

Antonella Fioravanti

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26031574%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

Elodia Claudia Martino

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26031574%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

Claudia Gandolfo

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26031574%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

Marco Pagliuchi

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26031574%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

Assunta Basile

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26031574%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

Veronica Ricci

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26031574%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

Lucia Micheli

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26031574%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

Luigi Pirtoli

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26031574%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

publication date

2 June 2015

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26031574%20AND%20SRC:MED&resulttype=core&format=json

Cancer Immunology, Immunotherapy

16 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26031574%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

volume

64

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26031574%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

issue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26031574%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

page(s)

1159-1173

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26031574%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s00262-015-1711-7

16 February 2020

exact match

0 references

cites work

Cancer immunotherapy.

1 reference

https://api.crossref.org/works/10.1007%2FS00262-015-1711-7

Translating tumor antigens into cancer vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-015-1711-7

Vaccines for the treatment of non-small cell lung cancer: investigational approaches and clinical experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-015-1711-7

Peptide-based anticancer vaccines: recent advances and future perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-015-1711-7

Human tumor antigens recognized by T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-015-1711-7

Identification of peptide sequences that potentially trigger HLA-A2.1-restricted cytotoxic T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-015-1711-7

Transcriptional activation and cell cycle block are the keys for 5-fluorouracil induced up-regulation of human thymidylate synthase expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-015-1711-7

Thymidylate synthase: a critical target in cancer therapy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-015-1711-7

New targets for pyrimidine antimetabolites in the treatment of solid tumours. 1: Thymidylate synthase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-015-1711-7

5-fluorouracil-based chemotherapy enhances the antitumor activity of a thymidylate synthase-directed polyepitopic peptide vaccine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-015-1711-7

In vitro generation of cytotoxic T lymphocytes against HLA-A2.1-restricted peptides derived from human thymidylate synthase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-015-1711-7

Chemotherapeutic drugs may be used to enhance the killing efficacy of human tumor antigen peptide-specific CTLs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-015-1711-7

Recruitment of dendritic cells and enhanced antigen-specific immune reactivity in cancer patients treated with hr-GM-CSF (Molgramostim) and hr-IL-2. results from a phase Ib clinical trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-015-1711-7

Dendritic cell-mediated cross-presentation of antigens derived from colon carcinoma cells exposed to a highly cytotoxic multidrug regimen with gemcitabine, oxaliplatin, 5-fluorouracil, and leucovorin, elicits a powerful human antigen-specific CTL re

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-015-1711-7

Chemo-immunotherapy of metastatic colorectal carcinoma with gemcitabine plus FOLFOX 4 followed by subcutaneous granulocyte macrophage colony-stimulating factor and interleukin-2 induces strong immunologic and antitumor activity in metastatic colon c

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-015-1711-7

Immunity feedback and clinical outcome in colon cancer patients undergoing chemoimmunotherapy with gemcitabine + FOLFOX followed by subcutaneous granulocyte macrophage colony-stimulating factor and aldesleukin (GOLFIG-1 Trial).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-015-1711-7

Multidisciplinary utilization of dimethyl sulfoxide: pharmacological, cellular, and molecular aspects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-015-1711-7

Modified Fibonacci search.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-015-1711-7

Immune-modulating effects of the newest cetuximab-based chemoimmunotherapy regimen in advanced colorectal cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-015-1711-7

A solid-phase enzyme-linked immunospot (ELISPOT) assay for enumeration of specific antibody-secreting cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-015-1711-7

Response definition criteria for ELISPOT assays revisited

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-015-1711-7

Novel adenoviral vector induces T-cell responses despite anti-adenoviral neutralizing antibodies in colorectal cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-015-1711-7

Validation of the EORTC QLQ-C30 quality of life questionnaire through combined qualitative and quantitative assessment of patient-observer agreement

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-015-1711-7

Immunity, Inflammation, and Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-015-1711-7

Autoimmunity associated with immunotherapy of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-015-1711-7

Cancer vaccines inducing antibody production: more pros than cons

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-015-1711-7

Cancer-related inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-015-1711-7

Changes in the local tumor microenvironment in recurrent cancers may explain the failure of vaccines after surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-015-1711-7

Immunomodulatory effects in a phase II study of lenalidomide combined with cetuximab in refractory KRAS-mutant metastatic colorectal cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-015-1711-7

Systemic inflammatory status at baseline predicts bevacizumab benefit in advanced non-small cell lung cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-015-1711-7

Advance lung cancer inflammation index (ALI) at diagnosis is a prognostic marker in patients with metastatic non-small cell lung cancer (NSCLC): a retrospective review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-015-1711-7

Prognostic role of neutrophil-to-lymphocyte ratio in solid tumors: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-015-1711-7

Gemcitabine, oxaliplatin, levofolinate, 5-fluorouracil, granulocyte-macrophage colony-stimulating factor, and interleukin-2 (GOLFIG) versus FOLFOX chemotherapy in metastatic colorectal cancer patients: the GOLFIG-2 multicentric open-label randomized

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-015-1711-7

The regulation of the development and function of dendritic cell subsets by GM-CSF: more than a hematopoietic growth factor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-015-1711-7

Myeloid-derived suppressor cells in multiple myeloma: pre-clinical research and translational opportunities

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-015-1711-7

Heterogeneity of CD4+ memory T cells: functional modules for tailored immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-015-1711-7

CCR7 coordinates the primary immune response by establishing functional microenvironments in secondary lymphoid organs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-015-1711-7

Central memory and effector memory T cell subsets: function, generation, and maintenance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-015-1711-7

Tumor infiltration by chemokine receptor 7 (CCR7)(+) T-lymphocytes is a favorable prognostic factor in metastatic colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-015-1711-7

Regulatory T cells and immune tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-015-1711-7

21 January 2018

A new look for the 1990s

1 reference

https://api.crossref.org/works/10.1007%2FS00262-015-1711-7